Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech STWD Q1 2026 Earnings EPS Misses Estimates by Nearly 10 BTMD Q1 2026 Earnings EPS Beats Estimates Stock Rises 26 ALEC Q1 2026 Earnings NarrowerThanExpected Loss Surprises No Revenue Yet Danaher Q1 2026 Earnings Earnings Per Share Beats Estimates Amid Slight Stock Pullback OPXS Q1 2026 Earnings Positive EPS Amid Modest Revenue Challenges